The store will not work correctly when cookies are disabled.
5-tert-Butyl-6-chloro-N-(4-fluorophenyl)pyrazine-2-carboxamide
ID: ALA495542
PubChem CID: 24881863
Max Phase: Preclinical
Molecular Formula: C15H15ClFN3O
Molecular Weight: 307.76
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)(C)c1ncc(C(=O)Nc2ccc(F)cc2)nc1Cl
Standard InChI: InChI=1S/C15H15ClFN3O/c1-15(2,3)12-13(16)20-11(8-18-12)14(21)19-10-6-4-9(17)5-7-10/h4-8H,1-3H3,(H,19,21)
Standard InChI Key: NFKBRWOBVLYDKY-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
4.3191 -24.4232 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3179 -25.2504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0327 -25.6633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.7491 -25.2500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7462 -24.4195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0309 -24.0104 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4591 -24.0043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1751 -24.4141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.4559 -23.1794 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8879 -23.9990 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6023 -24.4122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3146 -23.9977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3120 -23.1719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5910 -22.7623 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8816 -23.1791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6031 -25.6624 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8831 -26.0688 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0119 -26.3789 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1962 -24.9448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6045 -24.0108 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
10.0242 -22.7558 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
10 11 2 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
1 2 2 0
13 14 1 0
5 7 1 0
14 15 2 0
15 10 1 0
3 4 2 0
2 16 1 0
7 8 1 0
16 17 1 0
16 18 1 0
7 9 2 0
16 19 1 0
4 5 1 0
1 20 1 0
8 10 1 0
13 21 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 307.76 | Molecular Weight (Monoisotopic): 307.0888 | AlogP: 3.82 | #Rotatable Bonds: 2 |
Polar Surface Area: 54.88 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.71 | CX Basic pKa: ┄ | CX LogP: 3.91 | CX LogD: 3.91 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.92 | Np Likeness Score: -1.85 |
References
1. Dolezal M, Dolezal M, Cmedlova P, Palek L, Vinsova J, Kunes J, Buchta V, Jampilek J, Kralova K.. (2008) Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides., 43 (5): [PMID:17870211] [10.1016/j.ejmech.2007.07.013] |